Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
4DMedical Ltd ( (AU:4DX) ) has shared an update.
4DMedical Limited reported a substantial 202% increase in Q2 FY2025 operating revenue, driven by the growth of its SaaS products and expansion to 301 global sites. The company’s strategic partnerships, including a reseller agreement with Philips and key reference sites with major healthcare institutions, are expected to strengthen its market position and advance its commercial activities, particularly with the anticipated FDA clearance for its innovative CT:VQ™ product.
More about 4DMedical Ltd
4DMedical Limited is a respiratory imaging technology company specializing in advanced lung health solutions. It offers a range of SaaS products and imaging technologies, with a significant focus on expanding its global presence and enhancing diagnostic precision through partnerships.
YTD Price Performance: 25.00%
Average Trading Volume: 871,802
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$248.5M
See more data about 4DX stock on TipRanks’ Stock Analysis page.
